Pure Biologics Spólka Akcyjna Long-term Investment Intensity
Pure Biologics Spólka Akcyjna long-term investment intensity. Pure Biologics Spólka Akcyjna (PUR) has a Long-term Investment Intensity of 0.0% as of September 2022. Long-term investments of zł15.00 represent 0.0% of total assets of zł30.26 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read PUR total debt and obligations for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Pure Biologics Spólka Akcyjna (2021–2021)
Long-term investment intensity of Pure Biologics Spólka Akcyjna from 2021 to 2021. This chart shows how Pure Biologics Spólka Akcyjna's Long-term Investment Intensity has evolved across 1 annual periods from 2021 to 2021. As of September 2022, the intensity stands at 0.0%, reflecting long-term investments of zł15.00 against total assets of zł30.26 Million PLN.
Pure Biologics Spólka Akcyjna Long-term Investment Intensity by Year (2021–2021)
Pure Biologics Spólka Akcyjna long-term investment intensity by year from 2021 to 2021. The table below presents the year-by-year Long-term Investment Intensity for Pure Biologics Spólka Akcyjna from 2021 to 2021, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see PUR asset base.
| Year | LT Investment Intensity | LT Investments (PLN) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2021 | 0.0% | zł15.00 | zł47.19 Million | — |